...
首页> 外文期刊>The Biochemical Journal >INTERLEUKIN-13 IS A POTENT ACTIVATOR OF JAK3 AND STAT6 IN CELLS EXPRESSING INTERLEUKIN-2 RECEPTOR-GAMMA AND INTERLEUKIN-4 RECEPTOR-ALPHA
【24h】

INTERLEUKIN-13 IS A POTENT ACTIVATOR OF JAK3 AND STAT6 IN CELLS EXPRESSING INTERLEUKIN-2 RECEPTOR-GAMMA AND INTERLEUKIN-4 RECEPTOR-ALPHA

机译:白细胞介素13是表达白细胞介素2受体-γ和白细胞介素4受体-α的细胞中JAK3和STAT6的有效活化剂。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The lymphocyte growth factors interleukin-2 (IL2), IL4, IL7, IL9 and IL15 use the common IL2 receptor-gamma (IL2R gamma) and activate the IL2R gamma-associated tyrosine kinase JAK3 (Janus kinase 3). IL13 is structurally related to IL4, competes with IL4 for binding to cell surface receptors and exhibits many similar biological effects. The molecular basis for this functional overlap between IL4 and IL13 has been attributed mainly to a shared use of the 140 kDa IL4R alpha, since these cytokines appear to be uniquely different in that, according to several recent reports, IL13 does not recruit the IL2R gamma or JAK3. This notion has been supported by the identification of a novel 70 kDa IL13 receptor in certain IL13-responsive cell lines that lack IL2R gamma. The present study sheds new light on the issue of functional overlap between IL13 and IL4, by demonstrating for the first time that, in cells that express both IL2R gamma and IL4R alpha, IL13 can mimic IL4-induced heterodimerization of IL2R gamma and IL4R alpha, with consequent marked activation of JAK3 and the transcription factor STAT6 (IL4-STAT). Reconstitution experiments in BA/F3 cells showed that both cytokines require the simultaneous presence of IL4R alpha and IL2R gamma to mediate JAK3 and proliferative responses, and analysis of 12 IL4R alpha variants showed that IL4 and IL13 signals were equally affected by mutations of the cytoplasmic domain. We conclude that IL13 activates the IL2R gamma-associated JAK3 tyrosine kinase in appropriate cell types, and propose that IL13 is capable of interacting with multiple receptor subunits in a cell-dependent and combinatorial manner. Consequently, we predict that partial disruption of IL13 signal transduction also contributes to the severe combined immunodeficiency syndromes associated with inactivation of the IL2R gamma or JAK3 genes.
机译:淋巴细胞生长因子白介素2(IL2),IL4,IL7,IL9和IL15使用共同的IL2受体-γ(IL2Rγ)并激活与IL2Rγ相关的酪氨酸激酶JAK3(Janus激酶3)。 IL13在结构上与IL4相关,与IL4竞争结合细胞表面受体,并表现出许多相似的生物学效应。 IL4和IL13之间这种功能重叠的分子基础主要归因于140 kDa IL4Rα的共同使用,因为这些细胞因子似乎具有独特的不同,根据最近的一些报道,IL13不会募集IL2Rγ或JAK3。在缺乏IL2Rγ的某些IL13反应性细胞系中鉴定出新型的70 kDa IL13受体,为这一观点提供了支持。本研究首次证实在表达IL2Rγ和IL4Rα的细胞中,IL13可以模拟IL4诱导的IL2Rγ和IL4Rα的异二聚化,从而为IL13和IL4的功能重叠问题提供了新的思路。从而显着激活JAK3和转录因子STAT6(IL4-STAT)。在BA / F3细胞中进行的重组实验表明,两种细胞因子都需要同时存在IL4R alpha和IL2Rγ来介导JAK3和增殖反应,对12种IL4R alpha变体的分析表明,IL4和IL13信号同样受胞质域突变的影响。我们得出结论,IL13在适当的细胞类型中激活与IL2Rγ相关的JAK3酪氨酸激酶,并提出IL13能够以细胞依赖性和组合方式与多个受体亚基相互作用。因此,我们预测IL13信号转导的部分破坏也将导致与IL2Rγ或JAK3基因失活相关的严重的联合免疫缺陷综合症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号